Virtual care for respiratory health
NuvoAir's digital respiratory care platform empowers you to better manage your Asthma or COPD. Our dedicated care team and technology fit seamlessly into your routine and allow you and your doctor to make care decisions based on real-time data and insights.
Join today
How it works
An integrated respiratory health ecosystem to improve the lives of those suffering from lung conditions via data-driven insights, guided self-management, and high-touch care services
Best-in-class technology delivered to your door step
Award-winning connected spiorometer, mobile app, and analytics platform are easy to use. Our solution is FDA cleared and CE marked.
Self-management content and education
Personalized digital disease management content including live classes, on-demand breathing exercises and lifestyle tips allow you to better manage your symptoms and improve your quality of life
A care team dedicated to you available in 50 states
Our Care Coordinators and technology can detect when your respiratory health is changing and provide you with contextually relevant insights so you can take action.
Optimize your treatment by keeping your provider in the loop
Whether you are responding to a new treatment or feel an exacerbation starting, NuvoAir allows providers to follow your health status and make data driven care decisions in real time.
Care Coordinators across all 50 states
Technology can't solve all problems. That’s why our Care Coordinators help patients with managing their respiratory health at home. Our dedicated teams:
Coordinate your care pathway across acute hospital care through post-acute care management
Triage your data with your provider if you need medical attention
Deliver live classes to improve your wellness and promote lifestyle changes
Support you to carry out physiotherapy and pulmonary rehabilitation at home
Proven Results*
Thanks to the thousands of doctors, patients and researchers that have chosen us. We have proven that our respiratory platform makes a difference to the lives of patients.
NPS 75 Patients love us >95% Retention on our solution 39.9% Reduction of urgent consultations *Based on pilot study with Royal Brompton Hospital in London. 41 patients, mean age 37.3 years (SD 10.2), mean FEV1 57.3% predicted (range 24.2–103.0). Length of time using NuvoAir platform: mean 13.0 months (range 6.9–25.8).
Our Partners
Hospitals, universities, pharma companies and CROs around the world have chosen NuvoAir as their respiratory partner. We’re proud to support the work of forward-thinking, innovative players and researchers.
Join NuvoAir Today
We work with leading pharmaceutical companies, insurance plans and healthcare systems to offer NuvoAir at no
cost to people with respiratory conditions.
Answer a few quick questions to start your journey with NuvoAir.
Awards & Recognition
